19
Participants
Start Date
January 10, 2019
Primary Completion Date
December 20, 2022
Study Completion Date
December 20, 2022
P. vivax infected inoculum (parasitised red blood cells)
In the first controlled human malaria infection (CHMI, Phase A), inoculation of parasitised red blood cells will be at three different doses (1 vial, 1:5 dilution, 1:20 dilution). The optimal inoculation dose will then be selected and administered to all participants in each of the second and third CHMI.
Centre for Clinical Vaccinology & Tropical Medicine, Oxford
University of Oxford
OTHER